Author
Listed:
- Matthew Parker
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Kumarasamypet M. Mohankumar
(St. Jude Children’s Research Hospital)
- Chandanamali Punchihewa
(St. Jude Children’s Research Hospital)
- Ricardo Weinlich
(St. Jude Children’s Research Hospital)
- James D. Dalton
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Yongjin Li
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Ryan Lee
(St. Jude Children’s Research Hospital)
- Ruth G. Tatevossian
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Timothy N. Phoenix
(St. Jude Children’s Research Hospital)
- Radhika Thiruvenkatam
(St. Jude Children’s Research Hospital)
- Elsie White
(St. Jude Children’s Research Hospital)
- Bo Tang
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Wilda Orisme
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Kirti Gupta
(St. Jude Children’s Research Hospital)
- Michael Rusch
(St. Jude Children’s Research Hospital)
- Xiang Chen
(St. Jude Children’s Research Hospital)
- Yuxin Li
(St. Jude Children’s Research Hospital
Structural Biology, St. Jude Children’s Research Hospital)
- Panduka Nagahawhatte
(St. Jude Children’s Research Hospital)
- Erin Hedlund
(St. Jude Children’s Research Hospital)
- David Finkelstein
(St. Jude Children’s Research Hospital)
- Gang Wu
(St. Jude Children’s Research Hospital)
- Sheila Shurtleff
(St. Jude Children’s Research Hospital)
- John Easton
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Kristy Boggs
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Donald Yergeau
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Bhavin Vadodaria
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Heather L. Mulder
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Jared Becksfort
(St. Jude Children’s Research Hospital)
- Pankaj Gupta
(St. Jude Children’s Research Hospital)
- Robert Huether
(Structural Biology, St. Jude Children’s Research Hospital)
- Jing Ma
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Guangchun Song
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project)
- Amar Gajjar
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Thomas Merchant
(St. Jude Children’s Research Hospital)
- Frederick Boop
(St. Jude Children’s Research Hospital)
- Amy A. Smith
(MD Anderson Cancer Center Orlando, Pediatric Hematology/Oncology, 92 West Miller MP 318, Orlando, Florida 32806, USA)
- Li Ding
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis
Washington University School of Medicine in St Louis)
- Charles Lu
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis)
- Kerri Ochoa
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis
Washington University School of Medicine in St Louis)
- David Zhao
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Robert S. Fulton
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis)
- Lucinda L. Fulton
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis
Washington University School of Medicine in St Louis)
- Elaine R. Mardis
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis
Washington University School of Medicine in St Louis
Siteman Cancer Center, Washington University School of Medicine in St Louis)
- Richard K. Wilson
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
The Genome Institute, Washington University School of Medicine in St Louis
Washington University School of Medicine in St Louis
Siteman Cancer Center, Washington University School of Medicine in St Louis)
- James R. Downing
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Douglas R. Green
(St. Jude Children’s Research Hospital)
- Jinghui Zhang
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- David W. Ellison
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
- Richard J. Gilbertson
(St. Jude Children’s Research Hospital - Washington University Pediatric Cancer Genome Project
St. Jude Children’s Research Hospital)
Abstract
Members of the nuclear factor-κB (NF-κB) family of transcriptional regulators are central mediators of the cellular inflammatory response. Although constitutive NF-κB signalling is present in most human tumours, mutations in pathway members are rare, complicating efforts to understand and block aberrant NF-κB activity in cancer. Here we show that more than two-thirds of supratentorial ependymomas contain oncogenic fusions between RELA, the principal effector of canonical NF-κB signalling, and an uncharacterized gene, C11orf95. In each case, C11orf95–RELA fusions resulted from chromothripsis involving chromosome 11q13.1. C11orf95–RELA fusion proteins translocated spontaneously to the nucleus to activate NF-κB target genes, and rapidly transformed neural stem cells—the cell of origin of ependymoma—to form these tumours in mice. Our data identify a highly recurrent genetic alteration of RELA in human cancer, and the C11orf95–RELA fusion protein as a potential therapeutic target in supratentorial ependymoma.
Suggested Citation
Matthew Parker & Kumarasamypet M. Mohankumar & Chandanamali Punchihewa & Ricardo Weinlich & James D. Dalton & Yongjin Li & Ryan Lee & Ruth G. Tatevossian & Timothy N. Phoenix & Radhika Thiruvenkatam &, 2014.
"C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma,"
Nature, Nature, vol. 506(7489), pages 451-455, February.
Handle:
RePEc:nat:nature:v:506:y:2014:i:7489:d:10.1038_nature13109
DOI: 10.1038/nature13109
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Konstantin Okonechnikov & Aylin Camgöz & Owen Chapman & Sameena Wani & Donglim Esther Park & Jens-Martin Hübner & Abhijit Chakraborty & Meghana Pagadala & Rosalind Bump & Sahaana Chandran & Katerina K, 2023.
"3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma,"
Nature Communications, Nature, vol. 14(1), pages 1-16, December.
- Yanling Liu & Jonathon Klein & Richa Bajpai & Li Dong & Quang Tran & Pandurang Kolekar & Jenny L. Smith & Rhonda E. Ries & Benjamin J. Huang & Yi-Cheng Wang & Todd A. Alonzo & Liqing Tian & Heather L., 2023.
"Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication,"
Nature Communications, Nature, vol. 14(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:506:y:2014:i:7489:d:10.1038_nature13109. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.